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A B S T R A C T   
Background: Tuberculosis (TB) remains an urgent global public health priority, causing 1.5 million deaths 
worldwide in 2018. There is evidence that psychosocial factors modulate immune function; however, how this 
may influence TB risk or BCG vaccine response, and whether this pathway can be modified through social 
protection, has not been investigated. This paper aims to: a) systematically review evidence of how psychosocial 
factors influence the expression of biomarkers of immunity, and b) apply this general evidence to propose 
plausible TB-specific pathways for future study. 
Methods: Papers reporting on the impact of psychosocial stressors on immune biomarkers in relation to infectious 
disease risk were identified through a search of the databases MEDLINE, PsycINFO, Global Health and Psy-
cEXTRA alongside reference list and citation searching of key papers. Data extraction and critical appraisal were 
carried out using a standardised form. The findings were tabulated and synthesised narratively by infectious 
disease category, and used to propose plausible mechanisms for how psychosocial exposures might influence 
immune outcomes relevant to TB and BCG response. 
Results: 27,026 citations were identified, of which 51 met the inclusion criteria. The literature provides evidence 
of a relationship between psychosocial factors and immune biomarkers. While the direction and strength of 
associations is heterogenous, some overarching patterns emerged: adverse psychosocial factors (e.g. stress) were 
generally associated with compromised vaccine response and higher antibody titres to herpesviruses, and vice 
versa for positive psychosocial factors (e.g. social support). 
Conclusions: The evidence identifies pathways linking psychosocial factors and immune response: co-viral 
infection and immune suppression, both of which are potentially relevant to TB and BCG response. However, 
the heterogeneity in the strength and nature of the impact of psychosocial factors on immune function, and lack 
of research on the implications of this relationship for TB, underscore the need for TB-specific research.   
1. Introduction 
1.1. A bio-social approach to TB research 
With an estimated 1.5 million deaths worldwide in 2018, tubercu-
losis (TB) remains the leading cause of death from a single infectious 
agent (World Health Organization, 2019). 
Biomedical advances, including diagnostics, antibiotic treatment and 
the Bacille Calmette-Gu�erin (BCG) vaccine, are important contributors 
to the reduction in TB mortality and morbidity. However, it is widely 
acknowledged that TB is closely associated with social determinants, 
and is considered a sensitive marker of impoverished and unequal so-
cieties (Oxlade & Murray, 2012). As such, human development remains 
the biggest driver of TB incidence decline worldwide (Hargreaves et al., 
2011). 
Despite the pervasive role of social determinants in the epidemiology 
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and control of TB, research developments that explore biomedical and 
social lines of enquiry have proceeded largely independently, and ex-
amples of unified conceptual models linking biological and social de-
terminants of TB are rare. These theoretical models can inform a more 
holistic approach to tackling TB based on better integration of social 
development strategies and biomedical interventions (Dowd, Fletcher, 
& Boccia, 2018). 
1.2. VALIDATE project 
The VALIDATE project ‘Enhancing BCG Efficacy: the Social Technology 
Lab Initiative’ has attempted to bridge biomedical and social models by 
advocating for an environ-vaccinology approach to the research and 
development of vaccines against diseases of poverty like TB (Dowd et al., 
2018). According to this framework, social determinants can influence 
immunity and contribute to the differential efficacy of vaccines and 
susceptibility to disease often observed across populations of different 
socioeconomic status (Dowd et al., 2018). From this it follows that the 
response to existing or new immunisation tools can be enhanced by 
combining their administration with poverty-reduction strategies in 
order to boost the immunity of populations living in severely deprived 
conditions. 
This can be achieved through social protection interventions, a set of 
risk management measures that aim to prevent, manage, and overcome 
situations that adversely affect people’s wellbeing, which are widely 
implemented in low- and middle-income countries (LMICs) (Schmitt & De, 
2013). Social protection encompasses social security and safety net mea-
sures with the aim of raising people out of extreme poverty and protecting 
them from the risks and consequences of livelihood shocks (Adato, 2008). 
This includes social protection programmes implemented to improve 
resilience to natural disasters, which – like other social protection pro-
grammes – can lead to poverty-reduction and associated improvements in 
mental and physical health and wellbeing (Pelham, Clay, & Braunholz, 
2011). Such social protection interventions may reduce the burden of in-
fectious diseases like TB through a number of mechanisms, including 
improving socio-economic factors contributing to transmission of disease 
Box 1 
Background literature supporting the postulated conceptual framework. 
The biological and epidemiological plausibility of the postulated conceptual framework shown in Fig. 1 is supported by a variable quantity and 
quality of literature. The framework should therefore be interpreted as a visual representation of potential mechanisms, which will require 
future testing to confirm which putative causal pathways are supported. Below we discuss the evidence that is available for some of the main 
pathways in the conceptual framework. 
Social protection, poverty and TB. 
There is strong and consistent evidence that social protection interventions such as cash transfers and microfinance can reduce poverty and 
inequalities (Goldberg, 2005; Hagen-Zanker et al., 2016). There is also more limited evidence that they can influence risk factors relevant for TB, 
and very little evidence that they can directly impact TB outcomes, due to a paucity of studies of social protection interventions that specifically 
address TB (Boccia et al., 2011). However, a country’s social protection level has been shown to be inversely associated with TB prevalence, 
incidence and mortality, adjusting for various confounders (Siroka, Ponce, & Lonnroth, 2016). 
Social protection and psychosocial factors. 
Social protection interventions may affect psychological stress by acting on underlying drivers of stress such as poverty (i.e. inability to meet 
basic needs or needs that are deemed important to satisfy individual wellbeing or the wellbeing of family members) and severe socioeconomic 
inequalities. The effect of social protection on these two social determinants is well documented (Bastagli et al., 2016; World Bank, 2015). 
Additionally, by acting on poverty and inequalities, social protection not only improves material living conditions, but indirectly mitigates the 
sense of exclusion and injustice often reported by people living in poverty or exposed to inequalities, with associated improvements in psy-
chosocial stressors and mental health (Kilburn, Handa, Angeles, Tsoka, & Mvula, 2018; Natali, Handa, Peterman, Seidenfeld, & Tembo, 2018; 
Ozer, Fernald, Weber, Flynn, & VanderWeele, 2011; Powell-Jackson et al., 2016). 
Impacts of poverty on TB: material, psychosocial and behavioural. 
Poverty may influence health by multiple pathways, including material living conditions, psychosocial factors and health-related behaviours 
(Bartley, 2017). In the context of TB, the impact of material (e.g. overcrowding, malnutrition) and behavioural (e.g. smoking, diabetes) factors 
have been discussed extensively (Bothamley, 2005; Cegielski & McMurray, 2004; Dubos & Dubos, 1996; Harries et al., 2016). However, evi-
dence on the influence of psychosocial factors on TB outcomes is lacking. 
Psychosocial factors/mental health and TB. 
Given the association between TB and poverty (L€onnroth, Jaramillo, & Williams, 2009), and between poverty and chronic psychosocial stressors 
(Jani, 2013) and mental disorders (Lund et al., 2010), many TB patients are likely to have been exposed to various psychosocial factors prior to 
TB infection or the development of active disease. Indeed, TB patients are known to have a high prevalence of psychosocial factors such as stress 
and anxiety; for example, a study in South Africa found high levels of distress among TB patients, associated with underlying stressors such as 
poverty (Peltzer et al., 2012). 
In the 1950s Thomas Holmes, a physician at a Seattle sanatorium, found that individuals who had experienced stressors such as divorce, being 
widowed, or unemployment were more likely to contract TB and less likely to recover (Lerner, 1996). While the relationships between TB and 
psychosocial factors/mental health are complex and bidirectional (Sweetland et al., 2017), several cohort studies indicate that depression often 
precedes and is therefore possibly a risk factor for TB (Cheng, Liao, Lin, & Lai, 2017; Oh, Choi, Kim, Kim, & Cho, 2017). Further prospective 
studies are required to fully disentangle the complex causal pathways involved. 
Psychosocial factors/mental health and immunity. 
Psychosocial stressors are known to modulate the immune response. For example, those experiencing chronic stress have been shown to have 
reductions in the numbers of B-cells (Futterman, Wellisch, Zighelboim, Luna-Raines, & Weiner, 1996; Kiecolt-Glaser et al., 1987a, 1987b), 
T-cells (McKinnon, Weisse, Reynolds, Bowles, & Baum, 1989), and salivary IgA secretion (Deinzer, Kleineidam, Stiller-Winkler, Idel, & Bachg, 
2000; Jemmott et al., 1983; Jemmott & Magloire, 1988) compared with controls. Such associations occur via interactions between the central 
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nervous system (CNS), endocrine and immune systems. Stressors can activate the hypothalamic-pituitary-adrenal (HPA) and 
sympathetic-adrenal-medullary (SAM) axes, provoking the release of hormones including catecholamines (e.g. adrenaline) and glucocorticoids 
(e.g. cortisol), which can in turn modulate immune function. This may occur directly, by the hormone binding to immune cell-surface receptors, 
or indirectly, for example by inducing the dysregulation of cytokines such as IFNγ and interleukins (Glaser & Kiecolt-Glaser, 2005; Padgett & 
Glaser, 2003; Webster, Tonelli, & Sternberg, 2002). 
It is possible that mental health may mediate the relationship between psychosocial factors and immune response. While there is no existing 
evidence that directly tests this pathway in entirety, we postulate this as a plausible mechanism given evidence of the links between psychosocial 
factors and mental health and between mental health and immunity. For example, stressful life events can precipitate depressive episodes in 
vulnerable persons (Kendler, Karkowski, & Prescott, 1999), and childhood abuse or neglect increases risk of depression in adulthood (Pechtel & 
Pizzagalli, 2011). Additionally, evidence links mental health to immune function. A meta-analysis found that depression is associated with 
various immunological assays, including impairments in T-cell mediated activities and reduced NK cell counts and cytotoxicity (Zorrilla et al., 
2001). 
Psychosocial factors, immunity and TB outcomes. 
There are several biological pathways by which psychosocial factors could influence immune response to TB:  
a) There is evidence that psychosocial stressors can partially suppress certain aspects of immune function (Glaser & Kiecolt-Glaser, 2005). Given 
that protective immunity against M.tb depends on various innate and adaptive immune mechanisms, there are various pathways that could 
be disrupted by immune suppression. For example, the T-cell mediated immune response is vital in host control of M.tb infection. In 
particular, the capacity of CD4þ T-cells to produce IFNγ, which stimulates phagocytes to contain intracellular M.tb, is crucial. This is sup-
ported by studies of host genetic susceptibility showing that individuals with deficiencies in signalling pathways for the cytokines IFNγ and 
interleukin-12 (IL-12) have increased susceptibility to mycobacterial infection (Altare et al., 1998). Additionally, CD4þ T-cell decline in 
HIV-infected individuals is associated with increased susceptibility to TB disease (Lawn, Myer, Edwards, Bekker, & Wood, 2009). Given this, 
if psychosocial stress could suppress CD4þ T-cell proliferation and/or IFNγ secretion, this would likely reduce host ability to contain M.tb 
infection. A potential association between psychosocial stress and impaired T-cell immunity is supported by evidence in animal models. For 
example, rats exposed to repeated stress show significant decreases in mononuclear cell count, especially CD8þ T cells, and reduced IL-2 
production (Batuman, Sajewski, Ottenweller, Pitman, & Natelson, 1990), and mice exposed to experimental stressors show supressed pro-
duction of IFNγ (Curtin, Boyle, Mills, & Connor, 2009; Zhang, Okutsu, Kanemi, Gametchu, & Nagatomi, 2005). It is also supported by ev-
idence in humans. In medical students, stress due to examinations is associated with reduced overall numbers of T cells, as well as a reduction 
in helper T cell and suppressor T cell counts compared with 6 weeks earlier (Glaser et al., 1985; Kiecolt-Glaser et al., 1984). In addition, 
caregivers of dementia patients show poor HSV-1 specific memory T cell proliferation compared with controls (Glaser & Kiecolt-Glaser, 
1997). It is also possible that immune suppression could interfere with BCG response, perhaps through limiting the BCG-associated 
expansion of CD4þ and CD8þ T-cells (Godfrey, Uldrich, McCluskey, Rossjohn, & Moody, 2015) and release of IFNγ (Fletcher et al., 2016).  
b) There is evidence of an association between psychosocial stressors and herpesvirus infection and reactivation (Jenkins & Baum, 1995), and 
also between certain herpesviruses and TB (Cobelens, Nagelkerke, & Fletcher, 2018), suggesting a further plausible pathway. TB patients are 
more likely to be cytomegalovirus (CMV) seropositive (Olaleye, Omilabu, & Baba, 1990) and have higher titres of anti-CMV antibodies 
(Amran et al., 2016) (reflecting increased CMV exposure) compared with controls. This was demonstrated recently in a Ugandan cohort, in 
which increased CMV-specific immunoglobulin G levels were associated with active pulmonary TB (Stockdale et al., 2018). Similarly, the 
CMV-specific IFNγ response has been associated with a greater than twofold increased TB disease risk in infants (Muller et al., 2019). Indeed, 
active CMV infection could be involved in progression from latent TB infection to active disease, a proposal supported by the similarity in the 
two infections’ age-sex distributions (Cobelens et al., 2018). It is likely that the relationship between CMV and TB is bi-directional, and some 
of the observed association may be accounted for by their shared epidemiology and risk factors, especially poverty. However, in a prospective 
study in rural Uganda, CMV IgG was associated with increased risk of active TB disease up to 10 years before TB diagnosis (p¼0.006), 
suggesting that CMV may indeed be a risk factor for TB disease (Stockdale et al., 2019). Beyond CMV, fewer studies have investigated the link 
between other herpesviruses and TB. However, a study in Finland showed that EBV antibody levels were higher in patients with pulmonary 
TB than in controls (Nikoskelainen, Hannuksela, & Palva, 1974), and a study in Taiwan showed that TB patients have a higher rate of 
seropositivity (p¼0.01) and higher antibody titres (p¼0.006) for HHV-8 than matched controls (Su et al., 2015). In a study in Georgia, 
prevalence of HHV-2 prevalence was 92% in TB patients and 29% in controls; for CMV prevalence was 68.5% in TB patients 5.8% in healthy 
controls (Karalian, 2008).  
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(e.g. living conditions, hygiene and sanitation, access to healthcare), 
reducing psychosocial stress, and supporting immune function (see Box 1). 
The currently available vaccine against TB, Mycobacterium bovis BCG, 
represents a key proof-of-concept for the environ-vaccinology model. 
BCG is notoriously only partially effective; while it reliably protects 
against disseminated forms of TB including meningitis and miliary dis-
ease in infants, efficacy in protecting against pulmonary TB is highly 
variable across geographic populations, especially in adults (World 
Health Organization, 2018a). While there are several new TB candidate 
vaccines in development, some of which are in advanced stages of 
clinical trials, none of these are likely to become widely available in the 
near future (World Health Organization, 2018a). In the meantime, 
mathematical modelling studies suggest that combining existing 
biomedical tools against TB with social protection interventions would 
accelerate the global decline in TB incidence; for example, one model 
demonstrates that increasing social protection coverage – defined by the 
proportion of people covered by labour market protections, social 
assistance, and social insurance – to 100% (as set for one of the Sus-
tainable Development Goal 1 targets) could lead to a 76% reduction of 
TB incidence by 2035 (Carter et al., 2018). 
However, the mechanisms by which social protection might influ-
ence BCG response and TB risk are not understood. In particular, there 
has been little research on the potential role for social factors in the 
immune response to TB and BCG. This is despite evidence that improved 
BCG efficacy is associated with higher latitudes, an observation that may 
be partially accounted for by the variation in socio-economic conditions 
seen across latitudes (Wilson, Fineberg, & Colditz, 1995). For example, 
BCG response as measured by increase in interferon-γ (IFN-γ) production 
to Mycobacterium tuberculosis purified protein derivative (M.tb PPD) is 
much larger in adolescents in the UK than in Malawian adolescents 
(Lalor et al., 2009). 
1.3. Conceptual framework 
The conceptual model in Fig. 1 illustrates several pathways by which 
social protection interventions could alter immune function, via mate-
rial, psychosocial or behavioural pathways. In turn, modulated immune 
function may lead to better resilience against TB infection and disease or 
improved BCG response. 
The biological and epidemiological plausibility of this conceptual 
framework is supported by a variable quantity and quality of literature 
(Box 1). In particular, evidence on the effect of psychosocial factors on 
immunity remains inconclusive. Psychosocial theory postulates that 
vulnerability to disease is linked to psychological stress, in particular 
arising from perceptions and experiences of adverse living conditions 
and social inequalities compounded by a perceived lack of agency and 
control (Marmot & Wilkinson, 2001). 
A growing body of research in the field of psychoneuroimmunology 
explores how psychosocial stressors modulate the immune system, 
influencing infectious disease risk/outcomes (Kemeny & Schedlowski, 
2007) and vaccination response (Burns, Carroll, Ring, & Drayson, 
2003b). For example, in healthy volunteers inoculated with a respira-
tory virus, severity of infection and symptoms increased in a 
dose-response relationship with psychosocial stress index score (Cohen, 
Tyrrell, & Smith, 1991). However, while psychosocial influences on 
immune biomarkers have been investigated (see Box 1), and applied for 
example to human immunodeficiency virus (HIV) (Kemeny, 2003), the 
application of this knowledge to TB is lacking. 
1.4. Aims and objectives 
This paper seeks to address this research gap, reviewing existing 
literature on how psychosocial factors influence immunity, and applying 
this evidence to the context of TB. We focus on the relationship between 
psychosocial factors and immunity in relation to TB with the aim of 
drawing attention to this specific and understudied pathway vis a vis 
material and behavioural pathways between poverty and TB/immune 
function, which have been studied more extensively. This research will 
increase understandings of potential mechanisms underlying TB risk, 
and through its application within the VALIDATE project will contribute 
to the development of a more creative, interdisciplinary response to 
tackling TB, combining social protection interventions with existing 
biomedical tools. 
Firstly, to understand how psychosocial factors influence biomarkers 
Fig. 1. Conceptual framework. This conceptual framework depicts several pathways through which social protection interventions may affect TB outcomes. ‘TB 
outcomes’ here includes TB exposure, infection, disease, and adverse outcomes. In this paper we focus on the pathway linking psychosocial factors with biomarkers of 
immunity (orange boxes in the figure) and apply the findings to the context of TB. (For interpretation of the references to colour in this figure legend, the reader is 
referred to the Web version of this article.) 
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of immunity, a systematic literature review will be undertaken. This 
literature has not been systematically examined since 1993 (Van Rood, 
Bogaards, Goulmy, & Van Houwelingen, 1993). It is anticipated that no 
or very little existing literature will explore psychosocial influences on 
the immune response to TB specifically. Therefore, the scope of this 
review encompasses knowledge relating to any infectious disease. Sec-
ondly, these general findings will be used to make inferences about 
plausible mechanisms by which psychosocial factors could influence the 
expression of biomarkers of immunity in ways relevant to TB. 
While these proposed mechanisms are putative and will require 
further research to confirm or refute, the extrapolation of general find-
ings to TB is a valid exercise given that many markers of immune 
response are overlapping and not pathogen-specific. Various immune 
correlates have been shown to be significantly associated with increased 
risk of TB disease in case-control studies which control for non-specific 
immune activation in the host environment (Fletcher et al., 2016; Zak 
et al., 2016). While not diagnostic of TB disease, such markers are 
significantly associated with increased risk of developing TB disease and 
are therefore relevant to our conceptual framework. 
This paper has two aims, which are reflected in the structure of the 
paper:  
1. To systematically review research into psychosocial influences on 
immune function (reported in 3. Results)  
2. To use the existing general evidence to propose plausible TB-specific 
pathways for future study (reported in 4.2. Implications for TB and 
BCG response) 
2. Methods 
2.1. Inclusion criteria 
This systematic review sought to identify primary epidemiological 
research investigating the impact of psychosocial factors on the 
expression of biomarkers of immunity relevant to infectious diseases 
including TB (see Table 1). Included papers therefore assessed psycho-
social factors as exposures and immune biomarkers as outcomes. Studies 
that examine the impact of psychosocial stress on epidemiological or 
clinical evidence of infection, without assessment of immunological 
correlates, were excluded, given the review’s aims of understanding the 
biological pathways between psychosocial factors and infectious disease 
and applying the findings to TB. 
Following existing literature (Brunner, 2017), psychosocial factors of 
interest include stress, anxiety, stigma, isolation/exclusion, 
discrimination, control, demands, autonomy, lack of self-esteem and 
social support. However, most of the literature focuses on stress/anxiety 
and social support/isolation. Despite significant evidence that such 
factors are associated with various health outcomes (Martikainen, 
Bartley, & Lahelma, 2002), their definition and measurement varies 
widely and is often unclear (Epel et al., 2018). The term ‘stress’ is used to 
refer to stressful exposures/life events (both acute (short-term) and 
chronic (long-term)), the perception of such exposures, and associated 
physiological responses. Here, we included papers that defined psy-
chosocial factors by the factor itself (e.g. stressful life events) or 
perception thereof (e.g. anxiety), rather than by the physiological 
response (e.g. cortisol). These are usually measured using questionnaire 
tools, such as the Perceived Stress Scale (PSS), which assesses how often 
individuals have felt stressed during the past month based on several 
questions on a scale of 0 (never) to 4 (very often) (Cohen, Kamarck, & 
Mermelstein, 1983). We included papers with mental health as a 
mediator, but those looking solely at the impact of mental health on 
immunity without reference to underlying psychosocial causes were 
excluded. Since the findings had to be relevant to infections including 
TB, we only included papers presenting any changes in immune bio-
markers in relation to infectious disease risk. 
The review aimed to understand pathways relating commonly- 
experienced psychosocial stresses that are potentially amenable to 
modification by social protection to immune functioning in the general 
population. Therefore, studies of ‘extreme’ stressors, defined as situa-
tions involving intensely stressful experiences (either acute or chronic) 
not experienced by the general population, either because of their 
abrupt onset or catastrophic consequences (e.g. natural disasters, mili-
tary stressors, caregiving), are excluded, as these are distinct from the 
widespread poverty-related stressors commonly experienced in TB- 
affected communities. Moreover, studies in HIV-infected populations 
are excluded, as the immunosuppression acquired immunodeficiency 
syndrome (AIDS) entails is considered a strong effect modifier which 
could obscure the pattern of how psychosocial factors influence immune 
functioning in the general population. Similarly, laboratory and animal 
studies are excluded, as this review focuses on pathways between psy-
chosocial factors and immunity that operate in situ. 
2.2. Search strategy 
MEDLINE (1946–2018), PsycINFO (1806–2018) and Global Health 
(1910–2018) were searched from inception to 11/05/2018, combining 
free text terms and subject headings for psychosocial factors, immunity, 
and infectious disease including TB (shown in Appendix A). The search 
was restricted to papers in English and relating to humans. For grey 
literature, PsycEXTRA (1908–2018) was searched from inception to 15/ 
07/2018 using the same search strategy. Key reviews (Burns et al., 
2003b; Glaser & Kiecolt-Glaser, 2005; Kemeny & Schedlowski, 2007) 
had their reference lists examined and citation searching carried out 
using the Web of Science citation search tool. All references were im-
ported into EndNote, and duplicates deleted, followed by title, abstract, 
and full-text screening to assess eligibility. Finally, bibliographic 
screening of the included papers was undertaken. 
2.3. Data extraction 
Data were extracted using the form in Appendix B. This is adapted 
from the Cochrane EPOC group’s data collection form (Cochrane 
Effective Practice and Organisation of Care (EPOC), 2017). The extrac-
ted data were tabulated, detailing participants, methods and results of 
included studies. 
Table 1 
Inclusion criteria.  
Population  - Any age group in any geographic location  
- Exclude HIV-infected populations 
Exposure  - Psychosocial factors  
- Defined by psychosocial exposure or perception thereof, rather 
than solely the physiological response  
- Precedes onset of infectious disease (although include cross- 
sectional studies where directionality is unclear)  
- Exclude ‘extreme’ stressors 
Control  - Level of psychosocial factor (e.g. stress level), or no psychosocial 
factor (e.g. no childhood abuse) 
Outcome  - Biomarkers of immunity  
- Restrict to studies relating to infectious disease  
- Include vaccine response 
Study 
design  
- Original epidemiological studies  
- Exclude protocols, case reports (sample size must be >2), abstracts 
and conferences  
- Exclude commentaries and reviews  
- Exclude laboratory and animal studies  
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Fig. 2. Flow chart of literature search. Adapted from PRISMA 2009 Flow Diagram (Moher, Liberati, Tetzlaff, Altman, & The Prisma Group, 2009). 107 articles were 
excluded following full-text screening because they did not meet the inclusion criteria. The most common reasons for exclusion at this stage were: HIV-infected 
population, ‘extreme’ stressor, onset of infection precedes psychosocial stressor, and not relating to infectious disease. 
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2.4. Critical appraisal 
The quality of all included studies was assessed by commenting on 
the methods’ suitability for answering the review question at each 
relevant stage of the data extraction form. Comments were made 
following questions on the CASP checklists for cohort (Critical Appraisal 
Skills Programme, 2018b) and case-control (Critical Appraisal Skills 
Programme, 2018a) studies, and the AXIS tool for cross-sectional studies 
(EpiNet). This critical appraisal process informed a judgement on overall 
study quality: high, moderate or low. 
2.5. Synthesis 
The eligible studies identified through the systematic review of the 
literature were categorised into three thematic areas:  
1. Impact of psychosocial factors on immune response to vaccination. 
This was considered especially pertinent given our interest in un-
derstanding how social protection interventions could influence BCG 
vaccine response.  
2. Impact of psychosocial factors on immune response to herpesviruses. 
This was considered particularly relevant given the increasing evi-
dence indicating an association between herpesviruses and TB, dis-
cussed in Box 1. 
3. Impact of psychosocial factors on immunity to other infectious dis-
eases. This was considered relevant given the communicable nature 
of TB. 
Studies within each category often measured the same type of bio-
markers of immunity, although there remained significant heterogeneity 
even within categories. Nevertheless, the categorisation facilitated 
direct comparisons among studies where appropriate and allowed a 
more coherent synthesis of the study findings. 
Given the variety of study designs, psychosocial factors and immune 
biomarkers measured, and metrics for reporting findings, meta-analysis 
was deemed inappropriate. A narrative synthesis was therefore 
completed, separately by thematic area, using the tabulated data to 
draw out relevant findings and salient points regarding study design and 
methods. Within each study group, the findings were reviewed to 
identify whether direction and strength of association varied according 
to the psychosocial factors and immune biomarkers measured, or by 
study design and quality. Additionally, any mediation was reported. The 
collective evidence was assessed as to whether and how psychosocial 
factors influence biomarkers of immunity, and the extent to which the 
findings could be extrapolated to the case of TB. 
3. Results 
51 articles met the inclusion criteria (Fig. 2). Included studies fall 
into three broad thematic areas regarding their infectious disease 
application: vaccine response (18 studies), herpesviruses (19 studies) 
and other infections (14 studies). The vaccine response studies are pri-
marily longitudinal, whereas the herpesvirus and other infection studies 
are mostly cross-sectional. The median number of participants is 95 
overall: 78.5 for the vaccine response studies, 121 for the herpesvirus 
studies, and 109.5 for other infection studies. Study quality is highest for 
the vaccine response studies and lowest for the studies of other 
infections. 
3.1. Vaccine response studies 
18 papers out of 51 investigated the relationship between psycho-
social factors and vaccination response (Burns, Carroll, Drayson, 
Whitham, & Ring, 2003a; Burns, Carroll, Ring, Harrison, & Drayson, 
2002a; Burns, Drayson, Ring, & Carroll, 2002b; Gallagher, Phillips, 
Ferraro, Drayson, & Carroll, 2008a, 2008b; Hayney et al., 2003; Jabaaij 
et al., 1993; Jabaaij et al., 1996; Kohut, Cooper, Nickolaus, Russell, & 
Cunnick, 2002; Miller et al., 2004; Moynihan et al., 2004; O’Connor 
et al., 2013; Petry, Weems, & Livingstone, 1991; Phillips, Burns, Carroll, 
Ring, & Drayson, 2005; Phillips et al., 2006; Pressman et al., 2005; 
Segerstrom, Hardy, Evans, & Greenberg, 2012; Wu, Zimmerman, & Lin, 
2017). Findings are summarised in Fig. 3 and detailed in Appendix C. 
Most (16/18) vaccination studies were longitudinal (Fig. 3a), 
assessing psychosocial factors and administering vaccines at baseline, 
and following up participants to assess their response. The two cross- 
sectional studies (Burns et al., 2002a, 2002b) assessed psychosocial 
factors and vaccine response in previously-vaccinated participants. The 
most common infection vaccinated against was influenza (8 studies), 
with others including hepatitis A and B, meningitis A and C, pneumo-
coccal infections and human papillomavirus (HPV) (Fig. 3b). Various 
psychosocial factors were assessed, broadly relating to stress and social 
interactions (Fig. 3c). The most common biomarker of immunity 
measured was antibody titre, in 17 studies, although four additionally or 
instead measure cytokine levels in response to vaccination (Fig. 3d). 
Most studies are moderate- or high-quality, with only one low-quality 
study (Hayney et al., 2003) (Fig. 3e). 
The findings were varied. 14/18 studies gave mixed results, with 
significant associations only uncovered for some of the psychosocial 
factors and immune biomarkers measured. A further two studies showed 
a weak association, and two others no association (Fig. 3f). 
In general, where associations were observed, adverse psychosocial 
exposures (e.g. stress) were associated with compromised vaccine 
response, whereas positive psychosocial factors (e.g. social support) 
were associated with improved response (Fig. 3g). There were, however, 
some exceptions. For example, one study found that higher life event 
exposure and perceived stress were associated with protective antibody 
titres at five weeks, with the reverse true at five months (Burns et al., 
2003a). 
Four papers investigated mediation. In one, coping strategy medi-
ated the association between stressful life events and antibody titre: 
acceptance coping was protective whereas coping by substance use 
increased risk of having an inadequate antibody titre (Burns et al., 
2002a). In other studies, sleep quantity mediated the relationship be-
tween stress and antibody response (Miller et al., 2004), and stress 
mediated the association between loneliness and antibody titre (Press-
man et al., 2005). No other significant mediation effects were found. 
There was no apparent overall trend between study quality and as-
sociation strength. However, the amount of time between psychosocial 
assessment/vaccination and assessment of immune biomarkers seems to 
influence the findings, with studies with the longest follow-up showing 
the weakest associations (Jabaaij et al., 1996; Segerstrom et al., 2012; 
Wu et al., 2017). This variation is also seen within longitudinal studies, 
with some finding significant associations at early timepoints but not 
later during follow-up (Phillips et al., 2005, 2006; Wu et al., 2017). 
However, the relationship is not entirely straightforward, and varies 
according to the psychosocial factor and vaccine response assessed 
(Gallagher, Phillips, Ferraro, Drayson, & Carroll, 2008a). 
3.2. Herpesvirus studies 
19 studies explored the relationship between psychosocial factors 
and immune response to herpesviruses (Benschop, Jabaaij, Oostveen, 
Vingerhoets, & Ballieux, 1998; Brook, Christian, Hade, & Ruffin, 2017; 
Christian, Iams, Porter, & Glaser, 2012; Dowd, Palermo, Chyu, Adam, & 
McDade, 2014; Esterling, Antoni, Kumar, & Schneiderman, 1993; Floyd, 
Hesse, Boren, & Veksler, 2014; Garcia-Linares, Sanchez-Lorente, Coe, & 
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Fig. 3. Summary of vaccine response studies.  
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Fig. 4. Summary of herpesviruses studies.  
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Fig. 5. Summary of other infectious disease studies.  
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Martinez, 2004; Horn, Turkheimer, & Strachan, 2015; Hsu et al., 2016; 
Janicki-Deverts, Cohen, Doyle, Marsland, & Bosch, 2014; Kemeny, 
Cohen, Zegans, & Conant, 1989; Kiecolt-Glaser et al., 1987a; Panter--
Brick, Eggerman, Mojadidi, & McDade, 2008; Phillips, Carroll, Khan, & 
Moss, 2008; Rector et al., 2014; Sanchez-Lorente, Blasco-Ros, Coe, & 
Martinez, 2010; Shirtcliff, Coe, & Pollak, 2009; Slopen, McLaughlin, 
Dunn, & Koenen, 2013). Findings are summarised in Fig. 4 and detailed 
in Appendix D. 
13/19 studies were cross-sectional (Fig. 4a), assessing psychosocial 
exposures and immune outcomes at a single timepoint. The remaining 
six were longitudinal, either measuring psychosocial factors at baseline 
and immune response at follow-up, or involving repeated measures of 
both psychosocial and immunological factors. The herpesvirus most- 
commonly investigated was Epstein-Barr virus (EBV, in 11 studies), 
although herpes simplex viruses (HSV-1 and HSV-2) and cytomegalo-
virus (CMV) were also common (Fig. 4b). Various psychosocial factors 
were investigated, mostly relating to stress and social support (Fig. 4c). 
In most studies, the biomarker of immunity measured was antibody titre 
to a herpesvirus (Fig. 4d). Study quality was moderate in 14 studies, high 
in 4, and low in 1 (Fig. 4e). 
Results were extremely diverse, with nine studies showing strong 
results, five no evidence of associations between psychosocial factors 
and immunity, and the remaining five mixed or weak results (Fig. 4f). 
Notably, only one study was carried out in a low-income country (LIC) 
(Panter-Brick et al., 2008). Herpesviruses are much more common in 
LICs than high-income countries (HICs); in LICs where data is available, 
over 90% of the population are seropositive for CMV, compared with 
~40–70% in HICs (Manicklal, Emery, Lazzarotto, Boppana, & Gupta, 
2013). It is therefore difficult to extrapolate the findings from HICs to 
LICs, where TB is more common. However, given that antibody response 
studies are typically undertaken among the seropositive, the immune 
responses observed in this group in HICs can be used to infer likely re-
sponses among the seropositive in LICs. 
With only one exception, where associations were observed, adverse 
psychosocial exposures were associated with higher antibody titres to 
herpesviruses, whereas positive psychosocial factors were associated 
with lower antibody titres (Fig. 4g). High herpesvirus-specific antibody 
titres reflect greater herpesvirus exposure, and greater risk of immune 
exhaustion resulting in impaired immunity to other infections. There 
was no consistent relationship between the type of psychosocial factor or 
herpesvirus studied and the direction or strength of associations. How-
ever, given relatively few papers considered herpesviruses other than 
EBV (only five studies investigate HSV-1, and fewer for other herpes-
viruses), this cannot be concluded with certainty. Finally, there were no 
clear correlations between type of immune biomarker and strength of 
findings, because all studies measured antibody titre. In the three studies 
that measured total antibody concentrations, no associations were found 
between psychosocial factors and this biomarker, indicating that any 
significant associations were due to herpesvirus-specific antibodies 
rather than overall immune system changes (Garcia-Linares et al., 2004; 
Sanchez-Lorente et al., 2010; Shirtcliff et al., 2009). Moreover, in studies 
that measured any biomarker of immunity other than antibody titre or 
herpesvirus neutralising capacity, adverse psychosocial factors were 
associated with immune suppression rather than activation (Horn et al., 
2015; Kemeny et al., 1989; Kiecolt-Glaser et al., 1987a). 
Six papers undertook mediation analysis. Potential mediators 
investigated included lifestyle and behavioural factors, mental health, 
inflammation and cortisol. However, only one study found evidence of 
mediation: the follow-up intimate partner violence (IPV) study found 
that evolution and cessation of IPV mediated the recovery of HSV-1 
neutralisation (defined as the ability of saliva to inhibit the formation 
of virus-induced cytopathologic effects in cell cultures incubated with 
HSV-1) between baseline and follow-up in physically-abused women 
(Sanchez-Lorente et al., 2010). 
No overall pattern appeared between study quality and strength of 
findings. Cross-sectional studies more often gave strong findings, with 
53.8% of cross-sectional studies uncovering strong associations 
compared with 33.3% of longitudinal studies. This suggests that asso-
ciations found in cross-sectional studies could be partially attributable to 
relationships in the other direction, with immune response to herpes-
viruses somehow influencing psychosocial factors (e.g. if poor immune 
response increases risk of herpesvirus infection or reactivation, or 
worsens symptoms, this may be a cause of stress or stigmatisation) or, 
perhaps more likely, to common causes of both. 
3.3. Studies of other infectious diseases 
14 studies investigated the relationship between psychosocial factors 
and immunity in the context of infectious diseases other than vaccine 
response or herpesviruses. This includes four studies in chronic hepatitis 
B (CHB) patients (Aliabad et al., 2016; Bahramabadi et al., 2017; He, 
Gao, Li, & Zhao, 2014; Liu, Zhang, & Jiang, 2011), four relating to 
respiratory infections (Boyce et al., 1995; Drummond & Hewson-Bower, 
1997; Koh, Yong, Ng, & Chia, 2002; Schaubroeck, Jones, & Xie, 2001; 
Yang et al., 2002), and six relating to other infectious diseases (Caserta 
et al., 2008; Clays et al., 2005; Darwin, Murni, & Nurdin, 2017; Gro€er 
et al., 2011; Levy et al., 1991; Wouters et al., 2016). Findings are sum-
marised in Fig. 5 and detailed in Appendix E. 
Study design and quality were highly variable, something unsur-
prising given the variety of infectious diseases and biomarkers of im-
munity investigated. The results were also extremely heterogenous. 
More studies found that adverse psychosocial factors have a suppressive 
effect on immune function (nine studies) than have an enhancing effect 
(five studies). However, the relatively small number of studies and their 
diverse nature makes identifying any overarching trend difficult. 
Among CHB patients, anxiety was associated with reduced CD4þ T- 
cells and CD4þ/CD8þ ratio (Liu et al., 2011), and an increased per-
centage of CD36-positive monocytes (Aliabad et al., 2016), and both 
stress and anxiety were correlated with increased interleukin 10 (IL-10) 
level and IFNγ:IL-10 ratio (He et al., 2014). Psychosocial factors there-
fore appear to suppress some aspects of immunity while enhancing 
others in CHB patients. The respiratory infection and other infectious 
disease studies similarly indicate that psychosocial stressors can both 
suppress and enhance different aspects of immune function. 
The strength of the findings was also variable: three studies showed 
strong associations, eight were mixed, one was indirect, and two showed 
no association. Neither direction nor strength of findings seemed to vary 
by infectious disease investigated or immune biomarker measured. 
However, it is hard to detect patterns given the paucity of studies 
relating to each disease/biomarker. Similarly, no clear overall pattern 
exists between study quality and strength of findings. 
4. Discussion 
4.1. Summary of findings 
Overall, most studies (42/51) found some relationship between 
psychosocial factors and biomarkers of immunity. However, associa-
tions were generally only uncovered for some of the psychosocial factors 
and biomarkers investigated. Moreover, the direction and strength of 
associations were mixed and not dependent on the type of biomarker or 
psychosocial factor investigated. Some overarching patterns can be 
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cautiously identified: adverse psychosocial factors were often associated 
with compromised vaccine response and higher antibody titres to her-
pesviruses, with the reverse true for positive psychosocial factors. 
However, there were exceptions to both trends. 
Such inconsistency is perhaps unsurprising, given the breadth of 
psychosocial factors, immune biomarkers, and infectious diseases 
investigated. A possible explanation may also lie in the nature of the 
psychosocial stressors and their measurement, in particular whether 
they were acute or chronic stressors. Both evolutionary theory (McE-
wen, 1998) and studies in mice exposed to brief stressors (Glaser & 
Kiecolt-Glaser, 2005) suggest that acute stressors might enhance aspects 
of immune function, whereas chronic stressors are usually immuno-
suppressive. However, this cannot be demonstrated in our review since 
most of the studies included (whether cross-sectional or longitudinal) 
only measured psychosocial factors at a single timepoint, rendering it 
impossible to differentiate between chronic and acute stressors. 
A further interesting finding of the vaccine response studies is that 
the time between measurement of psychosocial factors and immune 
outcomes seems to matter for the strength and nature of findings, but in 
a complex manner. This is an important limitation of all the cross- 
sectional studies included: since immune system functioning is 
constantly fluctuating, immune activation measured at a given time-
point following a stressor may be followed by a period of immune 
suppression, and vice versa. More longitudinal studies are therefore 
required, measuring psychosocial exposures and immune outcomes at 
multiple timepoints. 
4.2. Implications for TB and BCG response 
Although the relationship between psychosocial factors and bio-
markers of immunity was investigated for various infectious diseases, no 
study examined this in relation to TB risk, progression from latent to 
active disease, or BCG response. This makes it impossible to draw direct 
conclusions for TB, meaning that future TB-specific research in this area 
is essential. However, inferences for TB can be made based on the 
general evidence. In particular, this review has found evidence sup-
porting two mechanisms through which psychosocial factors affect im-
mune response, both of which are potentially relevant to the 
immunological processes involved in TB and BCG response: 
4.2.1. Co-viral infection 
The studies in this review found that adverse psychosocial circum-
stances are generally associated with an increase in antibody titres to 
herpesviruses, suggesting that psychosocial factors could precipitate 
herpesvirus infection, reinfection or reactivation. This is consistent with 
evidence that individuals of low socio-economic position (something 
commonly associated with adverse psychosocial factors (Jani, 2013)) 
are more likely to be seropositive for CMV (Dowd, Aiello, & Alley, 2009) 
and have higher CMV-specific circulating antibody levels across the 
life-course (Dowd & Aiello, 2009). An increase in the CMV-specific IFNγ 
response (which, like increased antibody titre, indicates CMV exposure) 
has been associated with increased TB disease risk among infants 
(Muller et al., 2017) and a lower BCG antigen-specific T-cell response 
following vaccination (Fletcher et al., 2016). A plausible mechanism 
underlying such associations could be that herpesvirus-associated 
chronic immune activation of the T-cell response (Bekker et al., 2005; 
Elwenspoek et al., 2017; Fül€op, Larbi, & Pawelec, 2013; Slyker et al., 
2012) ultimately leads to immune exhaustion and senescence, reducing 
the host’s ability to respond to TB infection. For example, primary CMV 
infection is characterised by expansion of CMV-specific CD4þ and CD8þ
T-cells and natural killer (NK) cells, both of which are important for 
defence against TB (Fletcher et al., 2016; Muller et al., 2019). This 
herpesvirus-specific expansion can ultimately result in immune 
exhaustion, with CMV-specific NK cells showing reduced IFNγ secretion 
in response to other pathogens such as TB (Cobelens et al., 2018). 
Moreover, expansion of CMV-specific T-cells, a phenomenon known as 
memory inflation (something associated with immune senescence), may 
displace naïve T-cells that could otherwise respond to M.tb antigens 
(White, Beard, & Barton, 2012). While CMV is used as an example here, 
it is not the only chronic viral infection known to be associated with TB 
(see Box 1), meaning that the proposed mechanisms are potentially 
more widely applicable. 
4.2.2. Immune suppression 
The studies in this review found that adverse psychosocial factors are 
generally associated with compromised immune response to vaccina-
tion, including influenza, hepatitis A and B, meningitis C and pneumo-
coccal vaccines. BCG is absent from this list, meaning that firm 
conclusions cannot be drawn about whether a similar effect would be 
seen of psychosocial factors on BCG response. However, it is a plausible 
future research avenue. Adverse psychosocial factors were generally 
associated with compromised vaccine response evidenced by reduced 
antibody titres, something relevant to TB given increasing evidence for 
the antibody response’s role in host defence against M.tb (Lu et al., 
2016). However, a few studies also investigated vaccine response by 
cytokine levels; for example psychosocial factors were associated with 
both antigen-specific IFNγ levels (Hayney et al., 2003) and 
antigen-specific IFNγ-producing cell frequencies (O’Connor et al., 
2013). This is particularly relevant to TB, given that IFNγ production by 
CD4þ T-cells is central to the immune response to BCG vaccination 
(Fletcher et al., 2016). An additional tentative pathway may be sug-
gested based on two studies in which stress and anxiety correlate with a 
reduced proportion of CD4þ and CD8þ T-cells among patients with 
chronic recurrent HSV (Kemeny et al., 1989) and CHB (Liu et al., 2011). 
These findings suggest a direct pathway by which adverse psychosocial 
factors could provoke immune suppression manifested as a lower pro-
portion of CD4þ and CD8þ T-cells. More indirectly, they could be a result 
of the pathway outlined above in which chronic immune activation due 
to persistent viral infection leads to T-cell exhaustion, precipitating 
reduced T-cell proliferation and cytokine production. A lower number 
and compromised cytokine-producing ability of CD4þ and CD8þ T-cells 
would likely lead to reduced IFNγ secretion and thus increased risk of TB 
disease. Evidence supports this; in infants, BCG-specific T-cells secreting 
IFNγ associate with reduced risk of TB (Fletcher et al., 2016). 
4.3. Strengths and limitations 
This study represents the first attempt to systematically assess the 
association between a wide range of psychosocial factors and bio-
markers of immunity and apply this knowledge to strengthen our un-
derstanding of the impact of psychosocial factors on BCG response. 
However, the lack of TB-specific evidence means that our review can 
only produce provisional hypotheses in this respect. Other limitations 
impose caution in drawing conclusions: while synthesis across disparate 
studies has allowed the evidence to be brought together and analysed 
holistically, this diversity makes drawing direct comparisons between 
studies difficult, and meta-analysis inappropriate. Moreover, there 
remain gaps in the evidence base. Most studies are based in HICs, 
making it difficult to infer whether the findings hold for populations in 
LICs. 
An important limitation to take into consideration is that it is beyond 
the scope of the included studies to fully account for the upstream social 
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environment that underlies the stressors measured. While some studies 
adjust for education, income and/or occupation as underlying causes, 
this is not the case in all studies. Upward bias in the estimates of stressors 
is thus possible, since psychosocial stress is associated with socio- 
economic deprivation (Jani, 2013). For example, poverty may influ-
ence immunity via material or behavioural pathways in addition to 
psychosocial mechanisms (see Fig. 1), thus lack of adjustment for so-
cioeconomic factors or other pathways may overestimate the effect of 
stress. Given the complexity of the causal pathways involved, it is 
difficult to draw conclusions with certainty. However, that an effect of 
psychosocial stress on immunity is seen in longitudinal studies and 
across different population groups, and that the findings are consistent 
with experimental evidence in animals (Batuman et al., 1990; Curtin 
et al., 2009; Zhang et al., 2005), suggests that the possibility of a real 
effect of psychosocial factors on immunity should not be discounted. 
In all systematic reviews, publication bias is a risk, since studies with 
no or weak findings are less likely to be published. However, a robust 
approach was used to systematically identify relevant published litera-
ture. The large number of titles screened – 23,577 after de-duplication – 
the use of additional strategies beyond database searching including 
bibliographic screening and citation searching, and critical appraisal of 
included papers ensured a comprehensive examination of existing evi-
dence in this field. Whilst the review did not include non-English lan-
guage papers, ‘extreme’ stressors, HIV-infected populations, or 
laboratory studies, future reviews could focus on these categories. 
5. Conclusions 
This is the first study to our knowledge to systematically examine 
psychosocial influences on immunity since 1993 (Van Rood et al., 1993), 
and the first to apply the findings to TB and BCG response. Firstly, the 
reviewed evidence suggests that psychosocial factors can influence im-
mune response to infectious diseases and immunisation, but in a highly 
heterogeneous manner. This renders the current lack of TB-specific 
studies an important gap in the evidence base. Secondly, this review 
provides evidence to support the plausibility of the hypothesised con-
ceptual framework linking social protection interventions and BCG 
response, underscoring the need for further research to confirm or refute 
whether a psychosocial framework can describe the nature of the 
hypothesised relationship between social determinants and BCG vaccine 
response. Specifically, this review can postulate two pathways linking 
psychosocial factors to immune biomarkers relevant to TB: co-viral 
infection and suppressed immune response. Future research must 
confirm whether these mechanisms indeed hold true in the case of TB 
and BCG response. 
From a broader perspective, we postulate that better integration 
between social protection and BCG immunisation may improve vaccine 
response among severely deprived populations. To our knowledge, there 
is no evidence as yet about the influence of social protection and social 
policies in general on biomarkers of immunity. In particular, there is a 
significant paucity of data about the influence of social adversities on the 
immune response to TB. In addition, very little is known on how and the 
extent to which any alteration to these processes could be modified or 
recovered through interventions, like social protection, able to tackle 
adverse living conditions. Understanding the pathways between social 
determinants, psychosocial exposures, and immune response to TB and 
BCG, and whether these can be modulated by social protection policies, 
is therefore an important agenda for further research. 
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Appendix A. Search strategies 
MEDLINE search strategy:  
1. (Psychosocial or anxi* or depress* or stress*).mp. [mp¼title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]  
2. Psychosocial deprivation/  
3. exp Anxiety/  
4. exp Anxiety Disorders/  
5. exp Depression/  
6. exp Stress, psychological/  
7. 1 or 2 or 3 or 4 or 5 or 6 
8. (Immune OR Immunity OR Immunosuppress* OR Immunosenescence OR Immunology OR Immunological OR Psychoimmunology OR Psy-
choneuroimmunology OR Inflammation OR Inflammatory).mp. [mp¼title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]  
9. exp Immune system phenomena/  
10. exp Immune system/  
11. 8 or 9 or 10  
12. (Infect* or communicable or epidemic or bacteri* or virus or viral).mp. [mp¼title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, 
synonyms]  
13. exp Infection/ 
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14. exp Bacterial infections/  
15. exp Virus diseases/  
16. exp Parasitic diseases/  
17. (Tuberculosis or TB).mp. [mp¼title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]  
18. exp Tuberculosis/  
19. 12 or 13 or 14 or 15 or 16 or 17 or 18  
20. 7 and 11 and 19  
21. Limit 20 to (English language and humans) 
PsycINFO/PsycEXTRA search strategy:  
1. (Psychosocial or anxi* or depress* or stress*).mp. [mp¼title, abstract, heading word, table of contents, key concepts, original title, tests & 
measures]  
2. exp Psychosocial factors/  
3. exp Anxiety/  
4. exp Anxiety disorders/  
5. exp Recurrent depression/  
6. exp “Depression (emotion)”/  
7. exp Major depression/  
8. exp Stress/  
9. exp Social stress/  
10. exp Psychological stress/  
11. exp Chronic stress/  
12. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 
13. (Immune OR Immunity OR Immunosuppress* OR Immunosenescence OR Immunology OR Immunological OR Psychoimmunology OR Psy-
choneuroimmunology OR Inflammation OR Inflammatory).mp. [mp¼title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures]  
14. exp Immune system/  
15. exp Immunology/  
16. exp Inflammation  
17. 13 or 14 or 15 or 16  
18. (Infect* or communicable or epidemic or bacteri* or virus or viral).mp. [mp¼title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
19. exp Infectious disorders/  
20. (Tuberculosis or TB).mp. [mp¼title, abstract, heading word, table of contents, key concepts, original title, tests & measures]  
21. exp Tuberculosis/  
22. 18 or 19 or 20 or 21  
23. 12 and 17 and 22  
24. Limit 20 to (English language and human) 
Global Health search strategy:  
1. (Psychosocial or anxi* or depress* or stress*).mp. [mp¼abstract, title, original title, broad terms, heading words, identifiers, cabicodes]  
2. exp Psychosocial aspects/  
3. exp Anxiety/  
4. exp Depression/  
5. exp Stress/  
6. 1 or 2 or 3 or 4 or 5 
7. (Immune OR Immunity OR Immunosuppress* OR Immunosenescence OR Immunology OR Immunological OR Psychoimmunology OR Psy-
choneuroimmunology OR Inflammation OR Inflammatory).mp. [mp¼abstract, title, original title, broad terms, heading words, identifiers, 
cabicodes]  
8. exp Immune response/  
9. exp Immune system/  
10. exp Immunity/  
11. 7 or 8 or 9 or 10  
12. (Infect* or communicable or epidemic or bacteri* or virus or viral).mp. [mp¼title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
13. exp Infection/  
14. exp Infectious diseases/  
15. exp Bacterial diseases/ 
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16. exp Viral diseases/  
17. (Tuberculosis or TB).mp. [mp¼abstract, title, original title, broad terms, heading words, identifiers, cabicodes]  
18. exp Tuberculosis/  
19. 12 or 13 or 14 or 15 or 16 or 17 or 18  
20. 6 and 11 and 19  
21. Limit 20 to English language 
Appendix B. Data extraction/critical appraisal form   
Data Extraction Critical Appraisal 
General Information 
First author   
Year   
Title   
Participants 
Population   
Setting   
Sampling method   
Inclusion/exclusion criteria   
Sample size   
Response rate   
Sample characteristics   
Methods 
Aim of study   
Study design   
Description of methods   
Duration of follow-up (if relevant)   
Loss to follow-up (if relevant)   
Statistical methods used   
Variables 
Exposure variables (psychosocial factors)   
Measurement of exposure   
Outcome variables (biomarkers of immunity)   
Measurement of outcome   
Mediator variables   
Measurement of mediators   
Confounder variables   
Measurement of confounders   
Application to infectious disease   
Findings 
Strength of findings (none, weak, mixed, strong)   
Key findings   
Key conclusions of authors   
Notes 
Study quality overall judgement: high/moderate/low   
Other comments    
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
16
Appendix C. Vaccine response studies  
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
17
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
18
Appendix D. Herpesvirus studies  
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
19
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
20
Appendix E. Other infectious disease studies  
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
21
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
22
References 
Adato, M. (2008). Social protection: Opportunity for Africa. Washington, DC. United States: 
IFPRI policy brief.  
Aliabad, M. H. B., Jafari, E., Kakh, M. K., Nosratababadi, R., Bakhshi, H., 
Sheikhha, M. H., … Arababadi, M. K. (2016). Anxiety leads to up-regulation of CD36 
on the monocytes of chronic hepatitis B-infected patients. International Journal of 
Psychiatry in Medicine, 51(5), 467–475. 
Altare, F., Durandy, A., Lammas, D., Emile, J. F., Lamhamedi, S., Le Deist, F., … 
Casanova, J. L. (1998). Impairment of mycobacterial immunity in human 
interleukin-12 receptor deficiency. Science, 280(5368), 1432–1435. 
Amran, F. S., Kim, K., Lim, A., Thomson, R., Lee, S., Waterer, G., et al. (2016). Is 
pulmonary non-tuberculous mycobacterial disease linked with a high burden of 
latent cytomegalovirus? Journal of Clinical Immunology, 36(2), 113–116. 
Bahramabadi, R., Fathollahi, M. S., Hashemi, S. M., Arababadi, A. S., Arababadi, M. S., 
Yousefi-Daredor, H., … Arababadi, M. K. (2017). Serum levels of IL-6, IL-8, TNF- 
alpha, and TGF-beta in chronic HBV-infected patients: Effect of depression and 
anxiety. Laboratory Medicine, 49(1), 41–46. 
Bartley, M. (2017). Health inequality: An introduction to concepts, theories and methods (2nd 
ed.). Cambridge: Polity Press.  
Bastagli, F., Hagen-Zanker, J., Harman, L., Barca, V., Sturge, G., Schmidt, T., et al. 
(2016). Cash transfers: What does the evidence say? A rigorous review of programme 
impact and of the role of design and implementation features. London. 
Batuman, O. A., Sajewski, D., Ottenweller, J. E., Pitman, D. L., & Natelson, B. H. (1990). 
Effects of repeated stress on T cell numbers and function in rats. Brain, Behavior, and 
Immunity, 4(2), 105–117. 
Bekker, V., Bronke, C., Scherpbier, H. J., Weel, J. F., Jurriaans, S., Wertheim-van 
Dillen, P. M., … Kuijpers, T. W. (2005). Cytomegalovirus rather than HIV triggers the 
outgrowth of effector CD8þCD45RAþCD27- T cells in HIV-1-infected children. 
AIDS, 19(10), 1025–1034. 
Benschop, R. J., Jabaaij, L., Oostveen, F. G., Vingerhoets, A. J. J. M., & Ballieux, R. E. 
(1998). The influence of psychological stress on immunoregulation of latent Epstein- 
Barr virus. Stress Medicine, 14(1), 21–29. 
Boccia, D., Hargreaves, J., Lonnroth, K., Jaramillo, E., Weiss, J., Uplekar, M., … 
Evans, C. A. (2011). Cash transfer and microfinance interventions for tuberculosis 
control: Review of the impact evidence and policy implications. International Journal 
of Tuberculosis & Lung Disease, 15(Suppl 2), 37–49. 
Bothamley, G. H. (2005). Smoking and tuberculosis: A chance or causal association? 
Thorax, 60(7), 527. 
Boyce, W. T., Chesney, M., Alkon, A., Tschann, J. M., Adams, S., Chesterman, B., et al. 
(1995). Psychobiologic reactivity to stress and childhood respiratory illnesses: 
Results of two prospective studies. Psychosomatic Medicine, 57(5), 411–422. 
Brook, M. J., Christian, L. M., Hade, E. M., & Ruffin, M. T. (2017). The effect of perceived 
stress on Epstein-Barr virus antibody titers in Appalachian Ohio women. 
Neuroimmunomodulation, 24(2), 67–73. 
Brunner, E. (2017). Lecture at LSHTM “health inequalities: The psychosocial model”. 
February 2017. 
Burns, V. E., Carroll, D., Drayson, M., Whitham, M., & Ring, C. (2003). Life events, 
perceived stress and antibody response to influenza vaccination in young, healthy 
adults. Journal of Psychosomatic Research, 55(6), 569–572. 
Burns, V. E., Carroll, D., Ring, C., & Drayson, M. (2003). Antibody response to 
vaccination and psychosocial stress in humans: Relationships and mechanisms. 
Vaccine, 21(19/20), 2523–2534. 
Burns, V. E., Carroll, D., Ring, C., Harrison, L. K., & Drayson, M. (2002). Stress, coping, 
and hepatitis B antibody status. Psychosomatic Medicine, 64(2), 287–293. 
Burns, V. E., Drayson, M., Ring, C., & Carroll, D. (2002). Perceived stress and 
psychological well-being are associated with antibody status after meningitis C 
conjugate vaccination. Psychosomatic Medicine, 64(6), 963–970. 
Carter, D. J., Glaziou, P., L€onnroth, K., Siroka, A., Floyd, K., Weil, D., … Boccia, D. 
(2018). The impact of social protection and poverty elimination on global 
tuberculosis incidence: A statistical modelling analysis of sustainable development 
goal 1. Lancet, 6(5), e514–e522. 
Caserta, M. T., O’Connor, T. G., Wyman, P. A., Wang, H., Moynihan, J., Cross, W., … 
Jin, X. (2008). The associations between psychosocial stress and the frequency of 
illness, and innate and adaptive immune function in children. Brain, Behavior, and 
Immunity, 22(6), 933–940. 
Cegielski, J. P., & McMurray, D. N. (2004). The relationship between malnutrition and 
tuberculosis: Evidence from studies in humans and experimental animals. 
International Journal of Tuberculosis & Lung Disease, 8(3), 286–298. 
Cheng, K. C., Liao, K. F., Lin, C. L., & Lai, S. W. (2017). Increased risk of pulmonary 
tuberculosis in patients with depression: A cohort study in taiwan. Frontiers in 
Psychiatry, 8, 235. 
Christian, L. M., Iams, A. D., Porter, K., & Glaser, R. (2012). Epstein-Barr virus 
reactivation during pregnancy and postpartum: Effects of race and racial 
discrimination. Brain, Behavior, and Immunity, 26(8), 1280–1287. 
Clays, E., De Bacquer, D., Delanghe, J., Kittel, F., Van Renterghem, L., & De Backer, G. 
(2005). Associations between dimensions of job stress and biomarkers of 
inflammation and infection. Journal of Occupational and Environmental Medicine, 47 
(9), 878–883. 
Cobelens, F., Nagelkerke, N., & Fletcher, H. (2018). The convergent epidemiology of 
tuberculosis and human cytomegalovirus infection [version 2; referees: 2 approved]. 
F1000Research, 7, 280. 
Cochrane Effective Practice and Organisation of Care (EPOC). (2017). Data collection 
form. EPOC Resources for review authors. Available from: http://epoc.cochrane.org 
/epoc-specific-resources-review-authors [Accessed 28th March 2018]. 
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. 
Journal of Health and Social Behavior, 24(4), 385–396. 
Cohen, S., Tyrrell, D. A., & Smith, A. P. (1991). Psychological stress and susceptibility to 
the common cold. New England Journal of Medicine, 325(9), 606–612. 
Critical Appraisal Skills Programme. (2018). CASP case control study checklist. Available 
from: https://casp-uk.net/casp-tools-checklists/ Accessed 28th March 2018. 
Critical Appraisal Skills Programme. (2018). CASP cohort study checklist. Available from: 
https://casp-uk.net/casp-tools-checklists/ Accessed 28th March 2018. 
Curtin, N. M., Boyle, N. T., Mills, K. H., & Connor, T. J. (2009). Psychological stress 
suppresses innate IFN-gamma production via glucocorticoid receptor activation: 
Reversal by the anxiolytic chlordiazepoxide. Brain, Behavior, and Immunity, 23(4), 
535–547. 
Darwin, E., Murni, A. W., & Nurdin, A. E. (2017). The effect of psychological stress on 
mucosal IL-6 and Helicobacter pylori activity in functional dyspepsia. Acta Med 
Indones, 49(2), 99–104. 
Deinzer, R., Kleineidam, C., Stiller-Winkler, R., Idel, H., & Bachg, D. (2000). Prolonged 
reduction of salivary immunoglobulin A (sIgA) after a major academic exam. 
International Journal of Psychophysiology, 37(3), 219–232. 
Dowd, J. B., & Aiello, A. E. (2009). Socioeconomic differentials in immune response. 
Epidemiology, 20(6), 902–908. 
Dowd, J. B., Aiello, A. E., & Alley, D. E. (2009). Socioeconomic disparities in the 
seroprevalence of cytomegalovirus infection in the US population: NHANES III. 
Epidemiology and Infection, 137(1), 58–65. 
Dowd, J. B., Fletcher, H. A., & Boccia, D. (2018). Social determinants and BCG efficacy: A 
call for a socio-biological approach to TB prevention [version 1; referees: 2 
approved]. F1000Research, (224), 7. 
Dowd, J. B., Palermo, T., Chyu, L., Adam, E., & McDade, T. W. (2014). Race/ethnic and 
socioeconomic differences in stress and immune function in the National 
Longitudinal Study of Adolescent Health. Social Science & Medicine, 115, 49–55. 
Drummond, P. D., & Hewson-Bower, B. (1997). Increased psychosocial stress and 
decreased mucosal immunity in children with recurrent upper respiratory tract 
infections. Journal of Psychosomatic Research, 43(3), 271–278. 
Dubos, R., & Dubos, J. (1996). The white plague: Tuberculosis, man, and society. New 
Brunswick, N.J.: Rutgers University Press.  
Elwenspoek, M. M. C., Sias, K., Hengesch, X., Schaan, V. K., Leenen, F. A. D., Adams, P., 
… Turner, J. D. (2017). T cell immunosenescence after early life adversity: 
Association with cytomegalovirus infection. Frontiers in Immunology, 8, 1263-1263. 
Epel, E. S., Crosswell, A. D., Mayer, S. E., Prather, A. A., Slavich, G. M., Puterman, E., 
et al. (2018). More than a feeling: A unified view of stress measurement for 
population science. Frontiers in Neuroendocrinology, 49, 146–169. 
EpiNet. AXIS - appraisal tool. Available from: http://www.epinet.net/AXIS-Appraisa 
l-Tool Accessed 25th March 2018. 
Esterling, B. A., Antoni, M. H., Kumar, M., & Schneiderman, N. (1993). Defensiveness, 
trait anxiety, and Epstein-Barr viral capsid antigen antibody titers in healthy college 
students. Health Psychology, 12(2), 132–139. 
Fletcher, H. A., Snowden, M. A., Landry, B., Rida, W., Satti, I., Harris, S. A., … 
McShane, H. (2016). T-cell activation is an immune correlate of risk in BCG 
vaccinated infants. Nature Communications, 7, 11290. 
Floyd, K., Hesse, C., Boren, J. P., & Veksler, A. E. (2014). Affectionate communication 
can suppress immunity: Trait affection predicts antibodies to latent Epstein-Barr 
virus. Southern Communication Journal, 79(1), 2–13. 
Fül€op, T., Larbi, A., & Pawelec, G. (2013). Human T cell aging and the impact of 
persistent viral infections. Frontiers in Immunology, 4, 271-271. 
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
23
Futterman, A. D., Wellisch, D. K., Zighelboim, J., Luna-Raines, M., & Weiner, H. (1996). 
Psychological and immunological reactions of family members to patients 
undergoing bone marrow transplantation. Psychosomatic Medicine, 58(5), 472–480. 
Gallagher, S., Phillips, A. C., Ferraro, A. J., Drayson, M. T., & Carroll, D. (2008). 
Psychosocial factors are associated with the antibody response to both thymus- 
dependent and thymus-independent vaccines. Brain, Behavior, and Immunity, 22(4), 
456–460. 
Gallagher, S., Phillips, A. C., Ferraro, A. J., Drayson, M. T., & Carroll, D. (2008). Social 
support is positively associated with the immunoglobulin M response to vaccination 
with pneumococcal polysaccharides. Biological Psychology, 78(2), 211–215. 
Garcia-Linares, M., Sanchez-Lorente, S., Coe, C., & Martinez, M. (2004). Intimate male 
partner violence impairs immune control over herpes simplex virus type 1 in 
physically and psychologically abused women. Psychosomatic Medicine, 66(6), 
965–972. 
Glaser, R., & Kiecolt-Glaser, J. K. (1997). Chronic stress modulates the virus-specific 
immune response to latent herpes simplex virus type 1. Annals of Behavioral Medicine, 
19(2), 78–82. 
Glaser, R., & Kiecolt-Glaser, J. K. (2005). Stress-induced immune dysfunction: 
Implications for health. Nature Reviews Immunology, 5(3), 243–251. 
Glaser, R., Kiecolt-Glaser, J. K., Stout, J. C., Tarr, K. L., Speicher, C. E., & Holliday, J. E. 
(1985). Stress-related impairments in cellular immunity. Psychiatry Research, 16(3), 
233–239. 
Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J., & Moody, D. B. (2015). The 
burgeoning family of unconventional T cells. Nature Immunology, 16, 1114. 
Goldberg, N. (2005). Measuring the impact of microfinance: Taking stock of what we know. 
Washington DC, USA. 
Gro€er, M. W., Yolken, R. H., Xiao, J. C., Beckstead, J. W., Fuchs, D., Mohapatra, S. S., … 
Postolache, T. T. (2011). Prenatal depression and anxiety in Toxoplasma gondii- 
positive women. American Journal of Obstetrics and Gynecology, 204(5), 433.e431- 
437. 
Hagen-Zanker, J., Bastagli, F., Harman, L., Barca, V., Sturge, G., & Schmidt, T. (2016). 
Briefing: Understanding the impact of cash transfers: The evidence. London. 
Hargreaves, J. R., Boccia, D., Evans, C. A., Adato, M., Petticrew, M., & Porter, J. D. H. 
(2011). The social determinants of tuberculosis: From evidence to action. American 
Journal of Public Health, 101(4), 654–662. 
Harries, A. D., Kumar, A. M. V., Satyanarayana, S., Lin, Y., Zachariah, R., L€onnroth, K., 
et al. (2016). Addressing diabetes mellitus as part of the strategy for ending TB. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(3), 173–179. 
Hayney, M. S., Love, G. D., Buck, J. M., Ryff, C. D., Singer, B., & Muller, D. (2003). The 
association between psychosocial factors and vaccine-induced cytokine production. 
Vaccine, 21(19/20), 2428–2432. 
He, Y., Gao, H., Li, X., & Zhao, Y. (2014). Psychological stress exerts effects on 
pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine 
response. PLoS ONE [Electronic Resource], 9(8), e105530. 
Horn, E. E., Turkheimer, E., & Strachan, E. (2015). Psychological distress, emotional 
stability, and emotion regulation moderate dynamics of herpes simplex virus type 2 
recurrence. Annals of Behavioral Medicine, 49(2), 187–198. 
Hsu, P. C., Yolken, R. H., Postolache, T. T., Beckie, T. M., Munro, C. L., & Groer, M. W. 
(2016). Association of depressed mood with herpes simplex virus-2 immunoglobulin- 
G levels in pregnancy. Psychosomatic Medicine, 78(8), 966–972. 
Jabaaij, L., Grosheide, P. M., Heijtink, R. A., Duivenvoorden, H. J., Ballieux, R. E., & 
Vingerhoets, A. J. (1993). Influence of perceived psychological stress and distress on 
antibody response to low dose rDNA hepatitis B vaccine. Journal of Psychosomatic 
Research, 37(4), 361–369. 
Jabaaij, L., vanHattum, J., Vingerhoets, A., Oostveen, F. G., Duivenvoorden, H. J., & 
Ballieux, R. E. (1996). Modulation of immune response to rDNA hepatitis B 
vaccination by psychological stress. Journal of Psychosomatic Research, 41(2), 
129–137. 
Jani, N. (2013). Poverty & stress. Berkeley Scientific Journal, 18(1), 42–45. 
Janicki-Deverts, D., Cohen, S., Doyle, W. J., Marsland, A. L., & Bosch, J. (2014). 
Childhood environments and cytomegalovirus serostatus and reactivation in adults. 
Brain, Behavior, and Immunity, 40, 174–181. 
Jemmott, J. B., 3rd, Borysenko, J. Z., Borysenko, M., McClelland, D. C., Chapman, R., 
Meyer, D., et al. (1983). Academic stress, power motivation, and decrease in 
secretion rate of salivary secretory immunoglobulin A. Lancet, 1(8339), 1400–1402. 
Jemmott, J. B., 3rd, & Magloire, K. (1988). Academic stress, social support, and secretory 
immunoglobulin A. Journal of Personality and Social Psychology, 55(5), 803–810. 
Jenkins, F. J., & Baum, A. (1995). Stress and reactivation of latent herpes simplex virus: 
A fusion of behavioral medicine and molecular biology. Annals of Behavioral 
Medicine, 17(2), 116–123. 
Karalian, M. A. (2008). Chronic virus infections in combination with tubercular process. 
Georgian Medical News, 159, 40–43. 
Kemeny, M. E. (2003). An interdisciplinary research model to investigate psychosocial 
cofactors in disease: Application to HIV-1 pathogenesis. Brain, Behavior, and 
Immunity, 17(1), S62–S72. 
Kemeny, M. E., Cohen, F., Zegans, L. S., & Conant, M. A. (1989). Psychological and 
immunological predictors of genital herpes recurrence. Psychosomatic Medicine, 51 
(2), 195–208. 
Kemeny, M. E., & Schedlowski, M. (2007). Understanding the interaction between 
psychosocial stress and immune-related diseases: A stepwise progression. Brain, 
Behavior, and Immunity, 21(8), 1009–1018. 
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Causal relationship between 
stressful life events and the onset of major depression. American Journal of Psychiatry, 
156(6), 837–841. 
Kiecolt-Glaser, J. K., Fisher, L. D., Ogrocki, P., Stout, J. C., Speicher, C. E., & Glaser, R. 
(1987). Marital quality, marital disruption, and immune function. Psychosomatic 
Medicine, 49(1), 13–34. 
Kiecolt-Glaser, J. K., Garner, W., Speicher, C., Penn, G. M., Holliday, J., & Glaser, R. 
(1984). Psychosocial modifiers of immunocompetence in medical students. 
Psychosomatic Medicine, 46(1), 7–14. 
Kiecolt-Glaser, J. K., Glaser, R., Shuttleworth, E. C., Dyer, C. S., Ogrocki, P., & 
Speicher, C. E. (1987). Chronic stress and immunity in family caregivers of 
Alzheimer’s disease victims. Psychosomatic Medicine, 49(5), 523–535. 
Kilburn, K., Handa, S., Angeles, G., Tsoka, M., & Mvula, P. (2018). Paying for happiness: 
Experimental results from a large cash transfer program in Malawi. Journal of Policy 
Analysis and Management, 37(2), 331–356. 
Kohut, M. L., Cooper, M. M., Nickolaus, M. S., Russell, D. R., & Cunnick, J. E. (2002). 
Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly 
individuals. Journals of Gerontology Series A-Biological Sciences & Medical Sciences, 57 
(9), M557–M562. 
Koh, D., Yong, Y., Ng, V., & Chia, S. E. (2002). Stress, mucosal immunity, upper 
respiratory tract infections, and sickness absence. Journal of Occupational and 
Environmental Medicine, 44(11), 987–988. 
Lalor, M. K., Ben-Smith, A., Gorak-Stolinska, P., Weir, R. E., Floyd, S., Blitz, R., … 
Dockrell, H. M. (2009). Population differences in immune responses to Bacille 
Calmette-Gu�erin vaccination in infancy. The Journal of Infectious Diseases, 199(6), 
795–800. 
Lawn, S. D., Myer, L., Edwards, D., Bekker, L. G., & Wood, R. (2009). Short-term and 
long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral 
therapy in South Africa. AIDS, 23(13), 1717–1725. 
Lerner, B. H. (1996). Can stress cause disease? Revisiting the tuberculosis research of 
Thomas Holmes, 1949-1961. Annals of Internal Medicine, 124(7), 673–680. 
Levy, S. M., Herberman, R. B., Lee, J., Whiteside, T., Beadle, M., Heiden, L., et al. (1991). 
Persistently low natural killer cell activity, age, and environmental stress as 
predictors of infectious morbidity. Natural Immunity and Cell Growth Regulation, 10 
(6), 289–307. 
Liu, W. J., Zhang, Y. H., & Jiang, H. Y. (2011). Relationship of anxiety state with 
lymphocyte subsets and the effect of Chinese medical treatment on anxiety in 
patients with chronic hepatitis B. Chinese Journal of Integrative Medicine, 17(4), 
302–306. 
L€onnroth, K., Jaramillo, E., & Williams, B. G. (2009). Drivers of tuberculosis epidemics: 
The role of risk factors and social determinants. Social Science & Medicine, 68(12), 
2240–2246. 
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., … 
Alter, G. (2016). A functional role for antibodies in tuberculosis. Cell, 167(2), 
433–443. 
Lund, C., Breen, A., Flisher, A. J., Kakuma, R., Corrigall, J., Joska, J. A., … Patel, V. 
(2010). Poverty and common mental disorders in low and middle income countries: 
A systematic review. Social Science & Medicine, 71(3), 517–528. 
Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., & Gupta, R. K. (2013). The 
“silent” global burden of congenital cytomegalovirus. Clinical Microbiology Reviews, 
26(1), 86–102. 
Marmot, M., & Wilkinson, R. G. (2001). Psychosocial and material pathways in the 
relation between income and health: A response to Lynch et al. BMJ, 322(7296), 
1233–1236. 
Martikainen, P., Bartley, M., & Lahelma, E. (2002). Psychosocial determinants of health 
in social epidemiology. International Journal of Epidemiology, 31(6), 1091–1093. 
McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England 
Journal of Medicine, 338(3), 171–179. 
McKinnon, W., Weisse, C. S., Reynolds, C. P., Bowles, C. A., & Baum, A. (1989). Chronic 
stress, leukocyte subpopulations, and humoral response to latent viruses. Health 
Psychology, 8(4), 389–402. 
Miller, G. E., Cohen, S., Pressman, S., Barkin, A., Rabin, B. S., & Treanor, J. J. (2004). 
Psychological stress and antibody response to influenza vaccination: When is the 
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
24
critical period for stress, and how does it get inside the body? Psychosomatic 
Medicine, 66(2), 215–223. 
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The Prisma Group. (2009). Preferred 
reporting items for systematic reviews and meta-analyses: The PRISMA statement. 
PLoS Medicine, 6(7), e1000097. 
Moynihan, J. A., Larson, M. R., Treanor, J., Duberstein, P. R., Power, A., Shore, B., et al. 
(2004). Psychosocial factors and the response to influenza vaccination in older 
adults. Psychosomatic Medicine, 66(6), 950–953. 
Muller, J., Matsumiya, M., Snowden, M. A., Landry, B., Satti, I., Harris, S. A., Tanner, R., 
et al. (2017). Cytomegalovirus infection is a risk factor for TB disease in infants. bioRxiv, 
222646. 
Muller, J., Tanner, R., Matsumiya, M., Snowden, M. A., Landry, B., Satti, I., Harris, S. A., 
et al. (2019). Cytomegalovirus infection is a risk factor for TB disease in infants. JCI 
Insight, 130090.  
Natali, L., Handa, S., Peterman, A., Seidenfeld, D., & Tembo, G. (2018). Does money buy 
happiness? Evidence from an unconditional cash transfer in Zambia. SSM - 
Population Health, 4, 225–235. 
Nikoskelainen, J., Hannuksela, M., & Palva, T. (1974). Antibodies to Epstein-Barr virus 
and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis 
and erythema nodosum. Scandinavian Journal of Infectious Diseases, 6(3), 209–216. 
O’Connor, T. G., Winter, M. A., Hunn, J., Carnahan, J., Pressman, E. K., Glover, V., … 
Caserta, M. T. (2013). Prenatal maternal anxiety predicts reduced adaptive 
immunity in infants. Brain, Behavior, and Immunity, 32, 21–28. 
Oh, K. H., Choi, H., Kim, E. J., Kim, H. J., & Cho, S. I. (2017). Depression and risk of 
tuberculosis: A nationwide population-based cohort study. International Journal of 
Tuberculosis & Lung Disease, 21(7), 804–809. 
Olaleye, O. D., Omilabu, S. A., & Baba, S. S. (1990). Cytomegalovirus infection among 
tuberculosis patients in a chest hospital in Nigeria. Comparative Immunology, 
Microbiology and Infectious Diseases, 13(2), 101–106. 
Oxlade, O., & Murray, M. (2012). Tuberculosis and poverty: Why are the poor at greater 
risk in India? PLoS ONE [Electronic Resource], 7(11), e47533. 
Ozer, E. J., Fernald, L. C. H., Weber, A., Flynn, E. P., & VanderWeele, T. J. (2011). Does 
alleviating poverty affect mothers’ depressive symptoms? A quasi-experimental 
investigation of Mexico’s oportunidades programme. International Journal of 
Epidemiology, 40(6), 1565–1576. 
Padgett, D. A., & Glaser, R. (2003). How stress influences the immune response. Trends in 
Immunology, 24(8), 444–448. 
Panter-Brick, C., Eggerman, M., Mojadidi, A., & McDade, T. W. (2008). Social stressors, 
mental health, and physiological stress in an urban elite of young Afghans in Kabul. 
American Journal of Human Biology, 20(6), 627–641. 
Pechtel, P., & Pizzagalli, D. A. (2011). Effects of early life stress on cognitive and affective 
function: An integrated review of human literature. Psychopharmacology, 214(1), 
55–70. 
Pelham, L., Clay, E., & Braunholz, T. (2011). Natural disasters: What is the role for social 
safety nets?. Social Protection Discussion Paper No. 1102. 
Peltzer, K., Naidoo, P., Matseke, G., Louw, J., McHunu, G., & Tutshana, B. (2012). 
Prevalence of psychological distress and associated factors in tuberculosis patients in 
public primary care clinics in South Africa. BMC Psychiatry, 12(1), 89. 
Petry, L. J., Weems, L. B., & Livingstone, J. N. (1991). Relationship of stress, distress, and 
the immunological response to a recombinant hepatitis-B vaccine. Journal of Family 
Practice, 32(5), 481–486. 
Phillips, A. C., Burns, V. E., Carroll, D., Ring, C., & Drayson, M. (2005). The association 
between life events, social support, and antibody status following thymus-dependent 
and thymus-independent vaccinations in healthy young adults. Brain, Behavior, and 
Immunity, 19(4), 325–333. 
Phillips, A. C., Carroll, D., Bums, V. E., Ring, C., Macleod, J., & Drayson, M. (2006). 
Bereavement and marriage are associated with antibody response to influenza 
vaccination in the elderly. Brain, Behavior, and Immunity, 20(3), 279–289. 
Phillips, A. C., Carroll, D., Khan, N., & Moss, P. (2008). Cytomegalovirus is associated 
with depression and anxiety in older adults. Brain, Behavior, and Immunity, 22(1), 
52–55. 
Powell-Jackson, T., Pereira, S. K., Dutt, V., Tougher, S., Haldar, K., & Kumar, P. (2016). 
Cash transfers, maternal depression and emotional well-being: Quasi-experimental 
evidence from India’s Janani Suraksha Yojana programme. Social Science & Medicine, 
162, 210–218. 
Pressman, S. D., Cohen, S., Miller, G. E., Barkin, A., Rabin, B. S., & Treanor, J. J. (2005). 
Loneliness, social network size, and immune response to influenza vaccination in 
college freshmen. Health Psychology, 24(3), 297–306. 
Rector, J. L., Dowd, J. B., Loerbroks, A., Burns, V. E., Moss, P. A., Jarczok, M. N., … 
Bosch, J. A. (2014). Consistent associations between measures of psychological stress 
and CMV antibody levels in a large occupational sample. Brain, Behavior, and 
Immunity, 38, 133–141. 
Sanchez-Lorente, S., Blasco-Ros, C., Coe, C. L., & Martinez, M. (2010). Recovery of 
immune control over herpes simplex virus type 1 in female victims of intimate 
partner violence. Psychosomatic Medicine, 72(1), 97–106. 
Schaubroeck, J., Jones, J. R., & Xie, J. J. (2001). Individual differences in utilizing 
control to cope with job demands: Effects on susceptibility to infectious disease. 
Journal of Applied Psychology, 86(2), 265–278. 
Schmitt, V., & De, L. (2013). Social protection assessment-based national dialogue: A good 
practices guide. Bangkok. 
Segerstrom, S. C., Hardy, J. K., Evans, D. R., & Greenberg, R. N. (2012). Vulnerability, 
distress, and immune response to vaccination in older adults. Brain, Behavior, and 
Immunity, 26(5), 747–753. 
Shirtcliff, E. A., Coe, C. L., & Pollak, S. D. (2009). Early childhood stress is associated 
with elevated antibody levels to herpes simplex virus type 1. Proceedings of the 
National Academy of Sciences of the United States of America, 106(8), 2963–2967. 
Siroka, A., Ponce, N. A., & Lonnroth, K. (2016). Association between spending on social 
protection and tuberculosis burden: A global analysis. The Lancet Infectious Diseases, 
16(4), 473–479. 
Slopen, N., McLaughlin, K. A., Dunn, E. C., & Koenen, K. C. (2013). Childhood adversity 
and cell-mediated immunity in young adulthood: Does type and timing matter? 
Brain, Behavior, and Immunity, 28, 63–71. 
Slyker, J. A., Rowland-Jones, S. L., Dong, T., Reilly, M., Richardson, B., Emery, V. C., 
et al. (2012). Acute cytomegalovirus infection is associated with increased 
frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. 
Journal of Virology, 86(20), 11373–11379. 
Stockdale, L., Nash, S., Farmer, R., Raynes, J., Malikaarjun, S., Newton, R., & 
Fletcher, H. A. (2019). Cytomegalovirus antibody responses associated with increased 
risk of TB disease in Ugandan adults. The Journal of Infectious Diseases, jiz581.  
Stockdale, L., Nash, S., Nalwoga, A., Painter, H., Asiki, G., Fletcher, H., et al. (2018). 
Human cytomegalovirus epidemiology and relationship to tuberculosis and 
cardiovascular disease risk factors in a rural Ugandan cohort. PLoS ONE [Electronic 
Resource], 13(2), e0192086. 
Su, C. C., Lai, C. L., Tsao, S. M., Lin, M. N., Hsieh, T. C., Lu, J. J., et al. (2015). High 
prevalence of human herpesvirus type 8 infection in patients with pulmonary 
tuberculosis in Taiwan. Clinical Microbiology and Infections, 21(3), 266.e265-267. 
Sweetland, A. C., Kritski, A., Oquendo, M. A., Sublette, M. E., Norcini Pala, A., 
Silva, L. R. B., … Wainberg, M. L. (2017). Addressing the tuberculosis-depression 
syndemic to end the tuberculosis epidemic. International Journal of Tuberculosis & 
Lung Disease, 21(8), 852–861. 
Van Rood, Y. R., Bogaards, M., Goulmy, E., & Van Houwelingen, H. C. (1993). The effects 
of stress and relaxation on the in vitro immune response in man: A meta-analytic 
study. Journal of Behavioral Medicine, 16(2), 163–181. 
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002). Neuroendocrine regulation of 
immunity. Annual Review of Immunology, 20, 125–163. 
White, D. W., Beard, R. S., & Barton, E. S. (2012). Immune modulation during latent 
herpesvirus infection. Immunological Reviews, 245(1), 189–208. 
Wilson, M. E., Fineberg, H. V., & Colditz, G. A. (1995). Geographic latitude and the 
efficacy of bacillus Calmette-Guerin vaccine. Clinical Infectious Diseases, 20(4), 
982–991. 
World Bank. (2015). The state of social safety nets 2015. Washington, DC. 
World Health Organization. (2018). BCG vaccines: WHO position paper – february 2018. 
WHO Weekly Epidemiological Record, 8(93), 73–96. 
World Health Organization. (2019). Global tuberculosis report 2019. Geneva: WHO.  
Wouters, M. M., Van Wanrooy, S., Nguyen, A., Dooley, J., Aguilera-Lizarraga, J., Van 
Brabant, W., … Boeckxstaens, G. (2016). Psychological comorbidity increases the 
risk for postinfectious IBS partly by enhanced susceptibility to develop infectious 
gastroenteritis. Gut, 65(8), 1279–1288. 
Wu, R. F., Zimmerman, R. K., & Lin, C. J. (2017). The effect of perceived psychological 
stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in 
males. Human Vaccines & Immunotherapeutics, 13(3), 676–679. 
Yang, Y., Koh, D., Ng, V., Lee, C. Y., Chan, G., Dong, F., … Chia, S. E. (2002). Self 
perceived work related stress and the relation with salivary IgA and lysozyme among 
emergency department nurses. Occupational and Environmental Medicine, 59(12), 
836. 
S.E. Hayward et al.                                                                                                                                                                                                                             
SSM - Population Health 10 (2020) 100522
25
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., , … 
teams, G, C., & s, c. (2016). A prospective blood RNA signature for tuberculosis 
disease risk. Lancet, 387(10035), 2312–2322. 
Zhang, X., Okutsu, M., Kanemi, O., Gametchu, B., & Nagatomi, R. (2005). Repeated stress 
suppresses interferon-gamma production by murine intestinal intraepithelial 
lymphocytes. Tohoku Journal of Experimental Medicine, 206(3), 203–212. 
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., … 
Schmidt, K. (2001). The relationship of depression and stressors to immunological 
assays: A meta-analytic review. Brain, Behavior, and Immunity, 15(3), 199–226. 
S.E. Hayward et al.                                                                                                                                                                                                                             
